评估元学习器分析生存数据中的治疗异质性:应用于COVID-19大流行期间儿童哮喘护理的电子健康记录
该文提出基于伪个体化治疗效应的框架分析生存数据中的治疗异质性,包含元学习器、变量重要性指标和数据自适应亚组选择程序,并在多种观察性研究设定下评估有限样本性能。应用该框架分析书面哮喘行动计划对哮喘急性发作导致急诊返回时间的治疗异质性,使用大样本儿童哮喘电子健康记录数据集,识别出哮喘结局较差但从书面哮喘行动计划中获益增强的脆弱亚组。
要点
- 提出基于伪个体化治疗效应的框架,用于生存数据中治疗异质性的估计与亚组识别。
- 框架包含元学习器、变量重要性指标和数据自适应亚组选择程序。
- 在儿童哮喘电子健康记录中识别出从书面哮喘行动计划获益增强的脆弱亚组。
核心结论
- 该框架为分析生存数据中的治疗异质性提供了方法学工具,并在儿童哮喘电子健康记录应用中识别出从书面哮喘行动计划获益增强的脆弱亚组。
研究设计与样本
- 方法学研究,提出基于伪个体化治疗效应的框架,包含一组用于估计治疗异质性的元学习器、识别治疗异质性预测变量的变量重要性指标以及选择获益增强亚组的数据自适应程序。
- 在多种观察性研究设定下评估该框架的有限样本性能。
- 应用该框架分析书面哮喘行动计划对哮喘急性发作导致急诊返回时间的治疗异质性,使用大样本儿童哮喘电子健康记录数据集,访视记录从COVID-19大流行前扩展至大流行后。
主要发现
- 在多种观察性研究设定下评估了该框架的有限样本性能。
- 在儿童哮喘电子健康记录应用中识别出哮喘结局较差但从书面哮喘行动计划获益增强的脆弱亚组,并刻画了患者特征。
临床怎么用
- 作者认为该研究为医疗保健提供者战略性地分配书面哮喘行动计划提供了有价值的见解,特别是在破坏性公共卫生危机期间。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An important aspect of precision medicine focuses on characterizing diverse responses to treatment due to unique patient characteristics, also known as heterogeneous treatment effects (HTE) or individualized treatment effects (ITE), and identifying beneficial subgroups with enhanced treatment effects. Estimating HTE with right-censored data in observational studies remains challenging. In this paper, we propose a pseudo-ITE-based framework for analyzing HTE in survival data, which includes a group of meta-learners for estimating HTE, a variable importance metric for identifying predictive variables to HTE, and a data-adaptive procedure to select subgroups with enhanced treatment effects. We evaluate the finite sample performance of the framework under various observational study settings. Furthermore, we applied the proposed methods to analyze the treatment heterogeneity of a written asthma action plan (WAAP) on time-to-ED (Emergency Department) return due to asthma exacerbation using a large asthma electronic health records dataset with visit records expanded from pre- to post-COVID-19 pandemic. We identified vulnerable subgroups of patients with poorer asthma outcomes but enhanced benefits from WAAP and characterized patient profiles. Our research provides valuable insights for healthcare providers on the strategic distribution of WAAP, particularly during disruptive public health crises, ultimately improving the management and control of pediatric asthma.
引用
- Bo N, Jeong JH, Forno E, et al. Evaluating Meta-Learners to Analyze Treatment Heterogeneity in Survival Data: Application to Electronic Health Records of Pediatric Asthma Care in COVID-19 Pandemic. Stat Med. 2025. PMID: 39853815. doi:10.1002/sim.10333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。